Advancing The Utility Of Imaging Biomarkers: Insights From The Second Imaging Biomarker Summit
- Tags:
- Biomedical,
- Biomedical Imaging,
- Document Management,
- Enterprise Software,
- Finance,
- Imaging,
- Managerial Accounting,
- Software
- Source:
- IBM
FREE Registration is required
Overview: Biomedical imaging is becoming part of bio-pharmaceutical (BioPharma) R&D, in part due to advances in biomarkers - indicators of normal biological processes, pathogenic processes or BioPharma responses to a therapeutic intervention. As science and technology converge, imaging biomarkers will help screen and treat patients early in their disease process and help address some of society's costliest medical needs. Biomedical imaging plays an integral role in patient care, and can help support the diverse goals of BioPharma research, healthcare, academia and regulatory environments. To meet these goals, it is critical to align collaborative efforts to enhance the utility of imaging technology and thereby reduce overall healthcare and research costs.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 246KB | Date: Dec 2006 | Pages: 24
Top results from Business Consulting
» View all Business Consulting listings





